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SummAry
The use of human saliva as a diagnostic and prognostic fluid has until recently been somewhat disregarded. Although sample collection 
is non-invasive, physiological and genetic variations were largely responsible for its infrequent application in the past. recently, several 
proteomic studies contributed to partial elucidation of the salivary proteome (more than 2400 protein components have been character-
ized), both in terms of composition, contributions to whole saliva and genetic/physiological variability. on this basis, is not too optimistic 
to believe that in the near future human saliva could become a relevant diagnostic fluid. in this review, the characterization by proteomic 
approaches of new salivary markers in oncology, head and neck carcinoma (oral cavity, oropharynx, larynx, and salivary glands), breast 
and gastric cancers, salivary gland function and disease, Sjögren syndrome, systemic sclerosis, dental and gingival pathology, systemic, 
psychiatric and neurological diseases, is described.
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riASSunTo
L’uso della saliva umana come fluido corporeo diagnostico e prognostico è stato fino a poco tempo fa ignorato. Sebbene la metodica di rac-
colta salivare sia non invasiva, variabili fisiologiche e genetiche sono state considerate nel passato responsabili della scarsa applicabilità 
clinica del fluido salivare. Recentemente differenti studi proteomici hanno contribuito ad una parziale rappresentazione della proteomica 
salivare (finora sono state caratterizzate più di 2400 proteine), per quanto riguarda la composizione dell’intera saliva differenti studi sono 
stati condotti in relazione alla variabilità genetica e fisiologica. Alla luce di questi dati, non è troppo ottimistico pensare che nel futuro 
prossimo la saliva possa diventare un importante fluido diagnostico. In questa review, è stata descritta la caratterizzazione dell’approccio 
proteomico per identificare nuovi marker in oncologia, in particolare nei tumori maligni del distretto testa-collo (cavità orale, orofaringe, 
laringe e ghiandole salivari), della mammella e dello stomaco, nella patologie delle ghiandole salivari, nella sindrome di Sjogren, nella 
sclerosi sistemica, nelle patologie odontoiatriche incluse le parodontopatie, nelle malattie sistemiche, psichiatriche e neurologiche.
ParOle chiave: Saliva • Ghiandole salivari • Proteine • Peptidi • Proteomica • Cavità orale • Oncologia • Patologie odontoiatriche • 
Malattie sistemiche • Terapia
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Introduction
whole saliva is a unique body fluid continually bathing 
the mucosa of the oral cavity, oropharynx and larynx. it is 
a complex mixture deriving from the secretion of salivary 
glands, gingival fold and oral mucosa transudate, in addition 
to mucous of the nasal cavity and pharynx, non-adherent 
oral bacterial, food remainders, desquamated epithelial and 
blood cells, as well as traces of medications or chemical 
products 1. it is a clear, slightly acidic muco-serous exocrine 
secretion, composed of a variety of electrolytes, small or-
ganic substances, proteins, peptides and polynucleotides.
Saliva plays an important role in the maintenance of oral 
and tooth health, by means of antibacterial and antiviral 
activity, in the lubrication and repair of the oral mucosa 
and in the taste and digestion. About 65% of un-stimu-
lated (resting) saliva originates from the sub-mandibular 
gland, 25% from the parotid, 4% from the sublingual and 
8% from other salivary glands 2. These percentages vary 
under stimulation, principally for an increased contribu-
tion of parotid saliva.
Saliva represents an increasingly useful auxiliary means 
of diagnosis. however, since several factors can influence 
salivary secretion and composition a strictly standardized m. Castagnola et al.
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collection must be made so that a diagnostic exam might 
reflect the actual functioning of the salivary glands and 
serve as an efficient medium for monitoring health 3-7.
The ability to monitor health status, disease onset and 
progression and treatment outcome through non-invasive 
means is a highly desirable goal in healthcare manage-
ment. There are three prerequisites to this goal: i) the 
existence of specific biomarkers associated with a health 
or disease state; ii) a non-invasive approach to detect and 
monitor biomarkers; iii) appropriate technologies to dis-
criminate  biomarkers.  regarding  the  non-invasiveness 
of collection, saliva represents a suitable medium to be 
explored for health and disease surveillance. moreover, 
it offers further opportunities as a pool containing a vast 
repertoire  of  specific,  biologically-active  peptides  and 
proteins.
The recent availability of mass-spectrometry techniques 
has improved research in the salivary proteome and has 
produced qualitative and quantitative information on pro-
tein composition of saliva. recent proteomic approaches 
for human saliva analysis encompassed evaluation of pro-
tein concentration, expression, activation, modification, 
interaction and degradation and target protein function. 
These studies have highlighted the highly dynamic fea-
tures of salivary proteome 8. however, these are powerful 
techniques for the study of the proteome, the complete 
characterization of a body fluid proteome cannot proceed 
at the same speed of dnA sequencing and cannot have 
the same analytical robustness. moreover, the “quantita-
tive” aspect of the proteome, in contrast to the qualitative 
challenge of genomics, is essential in clinical applications 
because non-physiological levels of certain peptides/pro-
teins can reflect pathological conditions.
methodologies used for the isolation and identification 
of salivary proteins and peptides are principally based on 
high-performance  liquid  chromatography  (hPlc)  and 
2-d electrophoresis, in conjunction with mass spectrome-
try. Currently, more than 2400 salivary proteins have been 
identified, but it is expected that this number will increase 
in the near future. Saliva proteins are related to different 
functions: 21% are associated with immunity, 1.6% are 
associated with protein replication and reparation, 4.8% 
are associated with cell mobility and secretion, 2.3% with 
transcription and ribosomes, 4.2% with cell multiplica-
tion and cell cycle, 9.7% with signal transduction, 5.2% 
with metabolism and 7.1% with the cytoskeleton and en-
domembrane. of the remaining, 28.7% are proteins of 
uncertain and 15.4% of completely unknown function 9. 
however, it is important to outline that the attribution of 
the usual function to a protein occurring in saliva has to be 
carefully evaluated, because many proteins can exert dif-
ferent roles into different environments and many others 
possess multi-functional roles 10.
A large number of the protein and peptide classes belong-
ing to the human salivary proteome are specific to the oral 
cavity. each class is highly polymorphic, and leads to a 
large  inter-individual  variability  in  the  composition  of 
protein saliva. it is of interest to establish if some specific 
polymorphisms are related to pathological conditions or 
susceptibility to certain diseases.
Another problem in saliva analysis lies in physiological 
variations with biological rhythms and stimulations that 
can greatly modify its characteristics. Age also influences 
saliva composition, and that in paediatric and adult sub-
jects are characterized by different peptides 7 11 12.
The aim of this review is to describe the proteomic of 
salivary components to clarify the current status of this 
non-invasive approach in diagnosis, monitoring and pre-
vention of various systemic and local diseases.
Salivary gland function and disease
Salivary gland proteins
Saliva is responsible for the initial digestion of starch, 
mainly by the presence of salivary amylase (or ptyal-
in). This enzyme is considered to be a good indicator of 
proper functioning of the salivary glands, particularly of 
the parotid, contributing up to 20-30% of total protein 
in saliva. The majority of the enzyme (80%) is synthe-
sized in the parotids, and remainder in the submandibu-
lar glands.
major salivary glands secrete many other proteins and 
peptides, several specific to saliva, and numerous pub-
lications have been helped to elucidate the contribution 
of the different salivary glands to the salivary proteome. 
veerman  et  al. identified  four  specific  salivary  peptide 
families: proline-rich proteins (PrPs), statherins, S-type 
cystatins and histatins 13. The same authors identified the 
site of production: basic PrPs derive from parotid secre-
tion,  cystatins  from  sublingual/submandibular  glands, 
acidic PrPs and statherins from both parotid and sub-
lingual/submandibular glands. These findings have been 
recently confirmed and more thoroughly investigated in a 
top-down proteomic study 14.
hu et al. studied the submandibular and sublingual salivary 
proteome in relation to the health of the oral cavity and 
pathogenesis of certain diseases 15. They found a set of pro-
teins (cystatins, calgranulin and mucins) that are differen-
tially expressed in submandibular and sublingual secretions. 
hardt et al. investigated the parotid gland salivary proteome 
and peptidome, identifying different components of parotid 
saliva: cystatins, histatins, lysozyme, and isoforms and/or 
fragments of alpha-amylase, albumin and proline-rich pro-
teins 16. The authors also discovered novel proteins, such as 
several isoforms of Zn-alpha-2-glycoprotein and secretory 
actin-binding protein (Table i).
in addition, our group extensively studied the mechanism 
of salivary protein production by different proteomic in-
vestigations in animals 17 18 and humans 19 and clarified the 
structure of different salivary proteins and post-transla-Potential applications of human saliva as diagnostic fluid
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tional modification derivatives. in particular, we identified 
24 different histatin fragments 20, characterized the basic 
proline-rich protein complex 21, and studied the different 
statherins  and  PB  peptides  products  present  in  human 
whole saliva 22 23 (Table i). recently, we also investigated 
the trafficking and post-secretory events responsible for 
the formation of secreted human salivary peptides in order 
to clarify the localization of the post-translational modifi-
cations of the different classes of human salivary proteins 
and peptides (acidic and basic proline-rich proteins, histat-
ins, statherin, P-B peptide and “S type” cystatins) 14.
Concerning the minor salivary gland saliva, the proteome 
may be significantly different compared to parotid or sub-
mandibular/sublingual secretions. Siqueira et al. identi-
fied 56 proteins, 12 of which had never been previously 
identified in any salivary secretion 24. The unique charac-
teristics of the minor salivary gland secretion proteome 
are related to the types as well as the number of the com-
ponents present. in particular, it was shown that labial 
minor salivary glands secreted immunoglobulins, PrPs, 
cystatins, mucins, histatins, calgranulins and amylase as 
do other salivary glands (Table i), but 21% of all proteins 
identified were novel salivary proteins. it was concluded 
that differences between salivary proteomes may be im-
portant to specific oral functions.
A recent study on parotid gland exosomes by multidi-
mensional  protein  identification  technology  (MudPiT) 
identified 491 proteins in the exosome fraction of human 
parotid saliva. many of these proteins were previously ob-
served in ductal saliva from parotid glands (265 proteins). 
Cytosolic proteins comprised the largest category of exo-
some  parotid  proteins  involved  in  phosphatidylinositol 
signalling  system,  calcium  signalling  pathway,  inositol 
metabolism, protein export and signal transduction. inte-
gral plasma membrane proteins and associated/peripheral 
plasma membrane proteins were associated with extracel-
lular matrix-receptor interaction, epithelial cell signalling, 
T-cell and B-cell receptor signalling, cytokine receptor in-
teraction and antigen processing and presentation, among 
other biological functions. These putative saliva exosomal 
proteins were linked to specific diseases (neurodegenera-
tive disorders, prion disease, cancers, type i and ii dia-
betes).  Consequently,  parotid  glands  secrete  exosomes 
not only reflect the metabolic and functional status of the 
gland, but may also carry protein markers that are useful 
in the diagnosis of systemic diseases 25.
Table I. Different proteins in the salivary gland or whole saliva. 
Author, Year Proteins Salivary gland
de Almeida, 2008 4 Dextrins
Amylase
Statherin
Histatins (histidine-rich peptides)
Proline-rich proteins
Parotid (80%)
Submandibular (20%)
Veerman et al., 1996 13 PRPs
cystatins
acidic PRPs and statherins
Parotid/Sublingual/Submandibular
Parotid/Sublingual/Submandibular
Hu et al., 2004 39 Cystatin,
Calgranulin
Mucin
Submandibular/Sublingual
Hardt et al., 2005 16 Cystatins
Histatins
Lysozyme
Isoforms and/or fragments of alpha-amylase
Albumin
Proline-rich proteins
Isoforms of Zn-alpha-2-glycoprotein
Secretory actin-binding protein
Parotid
Castagnola et al., 2004 20 24 different histatin fragments Human whole saliva
Messana et al., 2004 21 Proline-rich protein complex Human whole saliva
Inzitari et al., 2006 22 Statherins Human whole saliva
Cabras et al., 2006 23 PB peptides products
Siqueira et al., 2008 24 Immunoglobulins
PRPS
Cystatins
Mucins
Histatins
Calgranulins
Amylase
Minor (labial)m. Castagnola et al.
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Salivary Gland Tumour
The role of proteomics in salivary gland neoplasm has 
been studied. nakashima et al. investigated the adenoid 
cystic carcinoma of the salivary glands and detected 4 up-
regulated and 5 downregulated proteins 26 (Table ii). They 
also found that maspin and stathmin showed a higher level 
of expression that correlated with histologic grading.
in our laboratory, we studied statherin levels in inflamma-
tory disease and in salivary glands tumours, but did not 
find any significant differences between patients affected 
by these pathologies and normal control subjects 27 (Ta-
ble ii).
An interesting field of clinical research regards metastasis 
of salivary gland tumours. one study showed that there 
is an important relationship between some proteins, such 
as transketolase, dim1p, v-ha-ras oncogene, type i colla-
gen pro alpha, tumour necrosis factor (ligand) superfami-
ly member 4, pirin and tumour metastasis 28. The same 
Authors also investigated the differential expression of 
proteins in adenoid cystic carcinoma with lung metasta-
sis. They found that transketolase, modulator recognition 
factor 2, dim1p homolog, splicing factor (arginine/serine-
rich 9) and v-ha-ras l oncogene were all hypo-expressed 
in poorly metastatic tumours and significantly up-regulat-
ed in highly metastatic tumours. moreover, they demon-
strated that type i collagen pro alpha and tumour necrosis 
factor showed a high expression in non-metastatic and 
a low expression in metastatic neoplasms. Finally, pirin 
was detected only in non-metastatic lesions, while retinal 
home box protein was only detected in metastatic tumours 
(Table ii).
Oncology
Head and neck carcinoma, tumours of the oral cavity
Proteomics has been applied to head and neck squamous 
cell carcinoma and tumours at sites distant from the oral 
cavity 29. various experimental studies have been carried 
out to clarify whether saliva possesses anti-carcinogenic 
activity 30 31.
Ohshiro et al. identified two proteins, alpha-1-B-glycopro-
tein and complement factor B proteins that were present in 
patients affected by head and neck squamous carcinoma; 
moreover, cystatin S, parotid secretory factor and poly-
4-hydrolase beta-subunit proteins were detected in most 
normal salivae, but not in that from patients 32. The Au-
thors  concluded  that  certain  proteins  are  differentially 
found in patients and normal saliva, and that a small set of 
proteins can be targeted for future validation for clinical 
investigation. initial evaluation of protein levels could be 
Table II. Proteins involved in oncological pathologies. 
Author, Year Proteins involved Proteins not involved Site of tumour
Nakashima et al., 2006 26 Maspin
Stathmin
Salivary gland
Contucci et al., 2005 27 Statherin Salivary gland
An et al., 2004 28 Transketolase
Dim1p
v-Ha-ras oncogene type I collagen 
pro alpha
Tumor necrosis factor pirin
Salivary gland with metastasis
Oshiro et al., 2007 32 Alpha-1-B-glycoprotein 
Complement factor B proteins
Cystatin S
Parotid secretory factor
Poly-4-hydrolase beta-subunit 
proteins
Head and neck
Dowling et al., 2008 33 Beta fibrin
S100 calcium binding protein
Transferrin
IG heavy chain constant region γ
Cofilin-1
Transthyretin
Head and neck
Mizukawa et al., 2001 35 Alpha-defensins
Beta-defensins
Oral cavity
Pickering et al., 2007 36 Endothelins Oral cavity
Contucci et al., 2005 27 Statherins Oral cavity
Wong, 2006 37  Interleukin-8 (IL-8) 
Thiredoxin
Oral cavity
Streckfus et al., 2000 41 c-erbB-2 protein
CA15-3
Breast
Tabak, 2001 42 15-3 cancer antigen BreastPotential applications of human saliva as diagnostic fluid
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a potential biomarker for malignant lesions of head and 
neck diseases (Table ii).
dowling et al. identified beta fibrin (+2.77-fold), S100 cal-
cium binding protein (+5.35-fold), transferrin (+3.37-fold), 
immunoglobulin heavy chain constant region gamma (+3.28 
fold) and cofilin-1 (+6.42 fold) significantly increased in sa-
liva from patients affected by head and neck squamous cell 
carcinoma compared to the control group, whereas transthy-
retin (-2.92 fold) was significantly decreased 33 (Table ii).
maier et al. observed that subjects with oral carcinoma 
showed a significantly limited function of the large sali-
vary glands, reflecting a reduction of the protective mech-
anisms of oral cavity and enabling an increased penetra-
tion of environmental carcinogens through the mucous 
surface 34.
mizukawa showed that alpha-defensins are highly repre-
sented  in  neutrophils  infiltrating  human  oral  squamous 
carcinoma tissue, while epidermoid cells and intermediate 
cells were intensely stained with anti-beta-defensin-2 as 
well as the epithelial hyperplasia region adjacent to tumour 
tissues. These findings imply a role for defensins in host 
defence against oral squamous cell carcinoma and could be 
relevant to local inflammatory processes 35 (Table ii).
Pickering et al. found significantly elevated salivary en-
dothelin levels in patients affected by oral squamous cell 
carcinoma  compared  with  normal  subjects,  concluding 
that these proteins may be useful to monitor patients at 
risk for oral neoplasms 36 (Table ii).
in a previous work by our group, we demonstrated a sig-
nificant reduction of statherin levels in the saliva of patients 
with precancerous and cancerous lesions of the oral cavity, 
but we were not able to demonstrate, until recently, if the 
decrease is a consequence of the lesion or if statherin might 
play a protective role in the oral cavity 27 (Table ii).
According to the results of wong, interleukin-8 (il-8) and 
thioredoxin are promising biomarkers for oral cancer 37 
(Table ii).
Another study by Xie et al. reported a novel proteomic ap-
proach that allowed characterization of the proteome of cells 
contained in whole saliva of patients diagnosed with oral sq-
uamous cell carcinoma. The authors described a catalogue 
of over 1000 human salivary proteins, including numerous 
proteins with a role in oral squamous cell carcinoma through 
signalling  and  tumourigenesis  pathways  38.  Additionally, 
proteins  from  over  30  different  bacteria  were  identified, 
some of which putatively contribute to cancer development. 
Also hu et al. recently identified 52 proteins in patients af-
fected by oral neoplasms, but not in normal subjects. The 
same authors reported that 29 proteins found in healthy sub-
jects were absent in patients with oral tumours 39.
Larynx
The  salivary  proteome  in  larynx  neoplasms  has  been 
poorly studied. Tomasik studied salivary protein modifi-
cations after radiotherapy for larynx carcinoma The au-
thors observed a reduction of α-amylase activity in saliva 
after irradiation, but these differences were not statisti-
cally significant due to the substantial decrease of other 
salivary proteins 40.
Other tumours
Breast cancer is the first systemic disease to be explored 
for the presence of proteomic signatures in the saliva. 
Streckfus has reported that c-erbB-2 protein and ca15-3 
levels are elevated in cancer respect to control saliva 41. 
Tabak also found CA15-3 in saliva and demonstrated the 
presence of soluble fragments in breast cancer patients 42 
(Table ii).
Bigler et al. demonstrated that proteomic analysis of saliva 
could be considered an excellent diagnostic technique for 
the detection of malignant tumours that are distant from 
the oral cavity 29.
using mass spectrometry, wu et al. explored the expres-
sion of saliva proteins in patients affected by gastric cancer. 
A total of 74 protein masses were found, and the levels of 
four peptides (1472.78 da, 2936.49 da, 6556.81 da and 
7081.17 da) were significantly different between gastric 
cancer patients and normal subjects. The positive identi-
fication rate for the peak intensity of these four peptides 
was significantly higher than that for the common serum 
cancer biological markers. it was concluded that a protein 
expression mass spectrum diagnosis model for classifica-
tion of gastric cancer and non-gastric cancer can be de-
veloped, thus providing a new tool for detection of early 
gastric cancer 43.
Sjögren syndrome
in the last few years, a growing interest has arisen in the 
application of proteomic analysis to rheumatic disease. 
Sjögren  syndrome  is  a  systemic  autoimmune  disease 
characterized by lymphocytic infiltration, destruction of 
the salivary and lachrymal glands and production of au-
toantibodies against a variety of cellular proteins. it in-
fluences the composition of human saliva and lachrymal 
fluid. Therefore, a rising number of studies have been per-
formed in an attempt to characterize the salivary protein 
profiles of patients with Sjögren syndrome by using a pro-
teomic approach 44-47.
giusti et al. studied the composition of human whole saliva 
and showed that the protein pattern was altered in Sjögren 
syndrome patients compared to a control group, with de-
creased levels of some salivary proteins. in particular, they 
demonstrated a remarkable alteration of carbonic anhy-
drase vi and proteins related to acute and chronic inflam-
mation and/or involved in oxidative stress injury. it was 
concluded that the findings are in line with the systemic 
immuno-inflammatory aspects of Sjögren’s syndrome and 
open the possibility for a systematic search of diagnostic 
biomarkers and targets for therapeutic intervention 44.m. Castagnola et al.
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ryu et al. investigated the parotid gland proteomic profile 
of patients affected by Sjögren syndrome and observed 
interesting changes in the expression of several proteins; 
they found a significant increase of beta-2-microglobulin, 
lactoferrin, immunoglobulin (ig) kappa light chain, poly-
meric ig receptor, lysozyme C and cystatin C in all stages 
of disease, and a decrease in two presumed proline-rich 
proteins, namely amylase and carbonic anhydrase vi 45.
Stea et al. also studied the parotid gland proteome of Sjö-
gren patients. They described high levels of post-transla-
tional modified la/SSB auto antigen and actin, whereas 
the native form of the protein was detected only faintly, in 
contrast to normal subjects 46.
Peluso et al. analyzed the proteomic modifications of sali-
vary peptides in patients with Sjögren syndrome before 
and after pilocarpine treatment 47. in adults, pilocarpine 
restored the levels of several salivary proteins. Compared 
to controls, saliva from patients showed higher levels of 
alpha-defensin 1 and beta-defensin 2 was also detected, 
suggesting that these peptides could be considered mark-
ers of oral inflammation in Sjögren patients 47. rigante 
et al. observed qualitative changes in a child with pri-
mary Sjögren syndrome after therapy, revealing clinical 
and functional differences of the salivary glands. in par-
ticular, after 6 months of treatment, all salivary proteins 
reached levels comparable to healthy individuals: 13 un-
known salivary proteins were the most abundant proteins 
observed before therapy and these decreased significantly 
after treatment. Fifteen basic PrPs, all deriving from pa-
rotid secretion, were absent before therapy while two (PD 
and ii-2) were reduced after therapy. Finally, acidic PrPs, 
histatins and statherins, which were found at low levels 
before therapy, returned to levels comparable with con-
trols after treatment 48.
Systemic sclerosis
recently, giusti et al. evaluated for the first time whole 
saliva protein profiles in patients with systemic sclerosis 
by a proteomic approach. it was found that the level of all 
the most representative salivary proteins, except keratin, 
remained unchanged and only qualitative differences were 
observed between control subjects and patients. it was 
also detected previously identified and newly identified 
proteins in saliva of patients: some of these, such as kera-
tin 6l, psoriasin, TPi, and arp2/3 complex, might have 
a pathological role in systemic sclerosis, suggesting that 
salivary proteins could be considered as new therapeutic 
targets or diagnostic markers for systemic sclerosis 44.
Dental and gingival pathology
Saliva is essential for a lifelong conservation of dentition. 
various functions of saliva have been implicated in main-
tenance of oral health and protection of teeth. in fact, the 
tooth surface is continuously protected against wear by a 
film of salivary mucins and proline-rich glycoprotein and 
the early pellicle proteins, proline-rich proteins and stath-
erin. These proteins promote remineralization of enamel 
by attracting calcium ions. moreover, demineralization is 
retarded by the pellicle proteins, together with calcium 
and phosphate ions in saliva and the plaque fluid. Finally, 
several salivary glycoproteins prevent the adherence of 
microorganisms to the enamel pellicle and inhibit their 
growth 49. (Table iii).
Thus, saliva plays an important role in dental and gingival 
physiology and pathology. in addition to saliva, other oral 
components, such as gingival crevicular fluid, epithelial 
cells, bacteria, breath and dental plaque have diagnostic 
potential. Correlative studies on salivary components and 
either caries or periodontal disease have not been conclu-
sive, but proteomic techniques on saliva appear promising 
in this regard 6 51.
Saliva buffer capacity and bacterial contents have been 
used mainly in dentistry and in studies on oral diseases to 
help assess the risk of caries 52. An interesting study has 
been conducted by vitorino et al. on the influence of sali-
vary protein composition on in vitro dental pellicle forma-
tion and its possible correlation with dental caries. The 
authors collected whole saliva from caries-free and car-
ies-susceptible subjects, and showed differences between 
the two groups in the levels of acidic proline-rich proteins, 
lipocalin and cystatins. moreover, subjects without caries 
presented high levels of amylase, immunoglobulin A and 
lactoferrin. As cystatins are known physiological inhibi-
tors of cathepsins, the higher quantities of lipocalin and 
cystatins in samples from caries-free subjects suggested 
that inhibition of proteolytic events on salivary proteins 
may indirectly provide tooth protection, also in consid-
eration of the protective role exerted by phosphorylated 
acidic PrPs 53 (Table iii).
ito et al. conducted a study on the relationship between 
antimicrobial  protein  levels  in  whole  saliva  and  peri-
odontitis. The authors compared the amounts of cystat-
ins and lysozyme in saliva of healthy subjects and those 
with periodontitis. Cystatin and lysozyme levels in saliva 
from those with periodontal disease were lower than that 
in the healthy group, indicating that they could be poten-
tial markers of an increased risk for periodontitis 54 (Ta-
ble iii).
other studies identified proteins related to the possible 
evolution  of  gingivitis  to  periodontitis;  these  salivary 
defence  proteins  are  immunoglobulin,  molecular  chap-
erone hsp70, cystatin S, salivary amylase, calprotectin, 
histatins,  lysozyme,  lactoferrin,  defensins,  peroxidases, 
proline-rich proteins and mucins 56 57(Table iii).
Concerning biomarkers related to periodontitis, Kibayashi 
et al. investigated the association between smoking, peri-
odontitis risk and salivary biomarkers 55 56. in particular, 
levels  of  prostaglandin  e(2),  lactoferrin,  albumin,  as-Potential applications of human saliva as diagnostic fluid
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partate aminotransferase, lactate dehydrogenase, and al-
kaline phosphatase were significantly lower in smokers, 
concluding that smoking exerted the greatest influence 
on periodontitis risk among lifestyle factors (Table iii). 
in fact, smoking may suppress the host defence system, 
which may promote progression of periodontal disease 57. 
nishida  et  al.  studied  the  association  between  passive 
smoking and salivary markers related to periodontitis, and 
showed that passive smoke exposure leads to elevation of 
il-1 beta, albumin and aspartate aminotransferase levels 
in saliva 58 (Table iii). wu et al. compared the proteomic 
profile  of  whole  un-stimulated  saliva  of  subjects  with 
generalized aggressive periodontitis with that of healthy 
volunteers. it was found that the proteomic profiles of the 
two groups showed at least 11 different proteins 9.
our group investigated peptides in human gingival crev-
icular fluid to examine the differences between this fluid 
and  saliva.  high  quantities  of  human  serum  albumin, 
alpha-defensins and minor amounts of cystatin A, stath-
erin, basic P-B salivary peptide were detected. in contrast, 
other peptides and proteins normally abundant in human 
saliva, such as proline-rich proteins and histatins, were 
not observed 59.
Another study from our group on statherin, a multifunc-
tional polypeptide specific to human saliva involved in oral 
calcium homeostasis, phosphate buffering and formation 
of protein networks, demonstrated that it is subjected, to-
gether with P-B peptide, to post-translational proteolytic 
cleavages, in part occurring in the oral cavity; this finding 
could be related to the normal physiology of the oral and 
dental microenvironment 22. rudney et al. studied levels of 
statherin and truncated cystatin S demonstrating that these 
proteins could be considered as a potential risk indicator 
for the development of caries and other oral disease 60.
in a recent study, thymosin beta (4), its sulphoxide and 
thymosin beta (10) were detected in human saliva and 
gingival crevicular fluid 61 62. The evaluation of their con-
centrations in both fluids indicated that the gingival sulcus 
is the main source of the two oral thymosins, endogenous 
agents contributing to the rapid healing of oral wounds. 
They could also facilitate re-epithelialization and modu-
late anti-inflammatory mediators.
Table III. Proteins involved in dental pathologies. 
Author, Year Proteins Related pathology
Van Nieuw et al., 2004 49; Dowd, 1999 50 Mucins
Proline-rich glycoprotein
Statherin
Dental caries
Vitorino et al., 2006 53 Proline-rich proteins
Lipocalin
Cystatins
Amylase
Immunoglobulin a
Lactoferrin
Dental caries
Rudney et al., 2009 60 Statherin
Truncated cystatin S
Dental caries and other diseases
Ito et al., 2008 54 Cystatins
Lysozyme
Periodontitis
Fábián et al., 2007 55; 2008 56 Immunoglobulin
Molecular chaperone hsp70
Cystatin S
Salivary amylase
Calprotectin
Histatins
Lysozyme
Lactoferrin
Defensins
Peroxidases
Proline-rich proteins
Mucins
Periodontitis
Kibayashi et al., 2007 57 Prostaglandin E(2)
Lactoferrin
Albumin
Aspartate aminotransferase  
lactate dehydrogenase
Alkaline phosphatase
Periodontitis
Nishida et al., 2006 58 IL-1 beta
Albumin
Aspartate aminotransferase
Periodontitism. Castagnola et al.
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in conclusion, the knowledge of functional properties of 
saliva as well as those of its separate components may 
permit a better assessment of susceptibility to dental car-
ies 50.
Future research is essential to characterize more salivary 
components  and  their  interactions,  and  determine  how 
these affect dental caries.
Other clinical applications
Saliva proteomics has been also examined in a number 
of  systemic  diseases  ranging  from  infectious  diseases 
(including hiv) to alzheimer’s disease 63, as well as in 
other chronic diseases such as pancreatitis, diabetes mel-
litus 64 65, renal insufficiency, anorexia, bulimia and celiac 
disease 4,6.
recently, walz et al. identified glycoprotein receptors for 
H. pylori in the human salivary proteome. Because the 
oral cavity is the entry point for gastric H. pylori, the in-
terest was in determining which glycoproteins are recog-
nized by the carbohydrate-binding adhesins of H. pylori, 
possibly resulting in modification of its surface or adhe-
sive properties 66.
Binding of H. pylori to salivary mucin muC7 is believed 
to be due to the activity of the SabA adhesin, binding to 
the salivary agglutinin gp-340 to the activity of the Baba 
adhesin, and binding to the high-molecular weight sali-
vary mucin MUc5B to the activity of the Baba adhesin 
and to a lesser degree to that of the SabA adhesion. Fur-
thermore, binding of H. pylori to the salivary PrG was 
newly detected and could be assigned to the activity of the 
Baba adhesin, whereas the Saba adhesin was account-
able for binding to additional, newly-discovered receptor 
molecules.
grigoriev in 2003 described that variations in psycho-
emotional state may alter the biochemical composition 
of  saliva;  depression,  in  particular,  is  accompanied  by 
reduced salivary proteins 67. Psychological stresses seem 
also induce significant changes in the salivary proteome. 
The increase of salivary amylase is a known proteomic 
indicator of psychological stress and sympathetic activa-
tion 56.
Johannsen et al. studied dental plaque, gingival inflam-
mation and levels of interleukin-6 and cortisol in gingival 
crevicular fluid from women with stress-related depres-
sion and exhaustion. it was found that these subjects had 
more  plaque  accumulation,  gingival  inflammation  and 
increased levels of il-6 and cortisol in gingival crevicu-
lar fluid compared to normal controls. These data suggest 
that depression might affect the immune function of sa-
liva, which could lead to impaired periodontal health 68.
Cabras  et  al.  analyzed  the  acidic  soluble  fraction  of 
whole saliva in type 1 diabetic children by reversed phase 
(rP)1–hPlceSi-MS  and  compared  it  to  that  of  sex- 
and  age-matched  control  subjects.  The  study  revealed 
that statherin, proline-rich peptide P-B, P-c peptide and 
histatins were significantly less concentrated in the saliva 
of diabetic subjects than in controls, while the levels of 
α-defensins 1, 2 and 4 and S100A9* were higher. The low 
concentration of P-c peptide was paralleled by high levels 
of some of its fragments. on the whole, the study high-
lighted the severe impairment of the repertoire of peptides 
involved in the safeguard of the oral cavity in children 
with type 1 diabetes, as well as a higher concentration 
of the proinflammatory mediator S100A9* compared to 
healthy children 69.
our group recently studied salivary peptides in subjects 
with a diagnosis of autism, identifying differences be-
tween patients and age-matched controls. in particular, 
the phosphorylation level of four specific salivary phos-
pho-peptides  (statherin,  histatin,  acid  proline  rich  pro-
teins) was significantly lower in a sub-group of autistic 
patients (about 60% of autistic patients analyzed). These 
results provide a clue regarding some potential molecular 
events at the basis of the disease, at least in a sub-group 
of  patients,  because  hypo-phosphorylation  of  salivary 
peptides could be related to potential asynchronies in the 
phosphorylation of other secretory proteins involved in 
the development of central nervous system 70. moreover, 
the analysis of saliva of autistic patients could be utilized 
to discriminate different aetiologies of this multi-factorial 
disease. nutritional deficiencies may also influence sali-
vary composition 4.
imanguli et al. investigated the changes in the salivary 
proteome following allogeneic haematopoietic stem cell 
transplantation (hCT) and found that transplantation was 
associated  with  long-term  changes  in  several  salivary 
proteins important for innate immune responses. in par-
ticular, the authors described that lactoferrin and secre-
tory leukocyte protease inhibitor showed elevations at 1 
month post-hCT that persisted at least 6 months, secre-
tory igA levels decreased 1 month post-transplant, with 
recovery at approximately 6 months; finally, levels of sali-
vary beta(2)-microglobulin were elevated at 6 months and 
correlated with secretory igA levels 71.
A recent paper by ozbay et al. described the presence of 
the multiple functional peptides in saliva, namely ghre-
lin and obestatin, which regulate energy homeostasis and 
food intake. These peptides were investigated in patients 
with ischaemic heart disease and healthy controls, and it 
was demonstrated that both obestatin and ghrelin were 
present in human salivary glands and saliva. even if no 
clear evidence on the role of these peptides in the context 
of ischaemic heart disease was found, it was concluded 
that determination of the salivary values of ghrelin and 
obestatin could represent a non-invasive alternative to se-
rum markers that can be useful in clinical practice 72.
moreover, there is an increasing interest on the diagnos-
tic role of salivary proteomics for systemic disease, such 
as cirrhosis, cystic fibrosis, but additional investigations Potential applications of human saliva as diagnostic fluid
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are needed. Salivary proteomics has also been proposed 
in prenatal diagnostic to develop markers for pregnancy 
related pathologies 73.
in the paediatric field, we investigated the modification 
of salivary proteins related to the development in human 
preterm and at-term newborns. we followed-up for one 
year the salivary acidic proline-rich proteins in these chil-
dren and showed that this class of proteins was constitu-
tive rather than inducible. moreover, we also demonstrat-
ed that these proteins were not fully mature in preterm 
newborns, but its phosphorylation levels were increased, 
synchronizing with that of at-term newborns and reaching 
adult values in concomitance with the beginning of decid-
uous dentition. 6 Another interesting finding by our group 
on salivary proteome concerned β-thymosins detected in 
whole saliva of human pre-term newborns at a concen-
tration inversely proportional to postmenstrual age and 
reaching a value more than 20 times higher than in adult 
whole saliva at 190 days of postmenstrual age. we also 
carried out an immunohistochemical analysis of major 
and minor salivary glands on autopsy samples from dif-
ferent pre-term foetuses, starting from 84 days (12 weeks) 
of gestational age. it was demonstrated that secretion of 
β-thymosins 4 and 10 increases from about 12 weeks until 
about 21 weeks of gestation, and subsequently decreases, 
almost disappearing in the period of expected date of de-
livery, when the gland switches towards the secretion of 
adult specific salivary peptides 74. These data showed, for 
the first time, that during foetal life salivary glands are 
active organs producing specific peptides, such as beta-
thymosins, which are probably relevant for the develop-
ment of the oral cavity and its annexes.
Conclusion
recently, there has been increasing interest in diagnosis 
based on analysis of saliva as its collection is simple and 
non-invasive. oral fluid sampling is safe for the both op-
erator and patient. These characteristics make it possible 
to monitor several biomarkers in infants, children, elderly 
and non-collaborative subjects, and in many circumstanc-
es in which blood and urine sampling is not available. The 
state-of-the-art  of  salivary  proteomics  is  progressively 
evolving and a growing number of clinical applications 
have been established to monitor local and systemic dis-
ease or conditions.
The most important research field of salivary proteomics 
is oncology; in fact, absence of several protective peptides 
or the presence of an altered protein salivary composition 
seems to represent a predisposing factor in cancerogen-
esis. however, some of the results obtained by different 
research groups do not overlap and are sometimes con-
tradictory. it is evident that many studies will require data 
validation and must be extended to a statistically signifi-
cant number of subjects.
Three is a definite need to identify definitive disease-as-
sociated salivary biomarkers with clinical relevance. Sali-
vary diagnostics for oral as well as systemic diseases is 
dependent on the identification of biomolecules, proteins 
and peptides, reflecting a characteristic change in pres-
ence, absence, composition or structure of saliva compo-
nents found under healthy conditions.
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